Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
2011

Identifying Genes Linked to Neuroblastoma Outcomes

Sample size: 59 publication 10 minutes Evidence: moderate

Author Information

Author(s): Carén Helena, Djos Anna, Nethander Maria, Sjöberg Rose-Marie, Kogner Per, Enström Camilla, Nilsson Staffan, Martinsson Tommy

Primary Institution: University of Gothenburg

Hypothesis

Can epigenetically regulated genes predict patient outcomes in neuroblastoma?

Conclusion

Low methylation frequency of certain genes is significantly associated with favorable outcomes in neuroblastoma.

Supporting Evidence

  • Eight genes were identified as methylated in neuroblastoma, some of which distinguish between biological subsets.
  • Differential methylation was observed for SCNN1A, PRKCDBP, and KRT19.
  • The mRNA expression of KRT19 and PRKCDBP was significantly lower in patients who died from the disease.

Takeaway

Researchers found that some genes can help predict how well children with neuroblastoma will do, based on their DNA changes.

Methodology

The study involved treating neuroblastoma cell lines with demethylating agents and analyzing gene expression and DNA methylation.

Limitations

The study had a relatively small sample size of 59 tumors, and findings need to be verified in larger cohorts.

Participant Demographics

Pediatric patients with neuroblastoma.

Statistical Information

P-Value

p = 0.01 for KRT19 and p = 0.04 for PRKCDBP

Confidence Interval

95% CI 1.7-19.1 for MYCN amplification

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2407-11-66

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication